Pharma

Your Article Summary

See Latest Articles

The biopharmaceutical industry must continuously evolve to keep up with changing trends
BioPharm, 04/09/09

Darwin demonstrated that all species evolve over time through the process of natural selection. The most adaptable prosper. The rest become fossilized remains. Darwin might see similarities in our evolving industry. Scientific advances have created enormous opportunities and challenges. Global partnering is complex and costly, and requires new ways of managing business relationships.

Today in Biotechnology...keeping you current

Receive free subspecialty "5-minute updates" via email

Development of biomaterial scaffold for nerve tissue engineering: Biomaterial mediated neural regeneration
BMC: Journal of Biomedical Science, 11/30/09

ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcoming ASH Annual Meeting and Exposition
ImmunoGen, Inc., 11/25/09

ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Companys TAP Technology
ImmunoGen, Inc., 11/20/09

 See all of Biotechnology

Today in Research & Development...keeping you current

Receive free subspecialty "5-minute updates" via email

Allos Therapeutics Announces Issuance of U.S. Patent for FOLOTYN
Allos Therapeutics, 12/01/09

New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents
Cell Therapeutics, 12/01/09

Bayer Starts Phase III Trial with Florbetaben
BayNews International, 12/01/09

 See all of Research & Development